No results for "Proteasome inhibitors" (auto) in titles.

Suggestions for article titles:

1. Proteasome inhibitor: Articles Most recent articles on Proteasome inhibitor Most cited articles on Proteasome inhibitor Review articles on Proteasome inhibitor Articles on Proteasome inhibitor in N Eng J Med, Lancet, BMJ Media Powerpoint slides on Proteasome inhibitor Images of Proteasome inhibitor Photos ... [100%] 2023-10-09 [Chemotherapeutic agents] [Inhibitors]...
2. Proteasome inhibitor: Proteasome inhibitors are drugs that block the action of proteasomes, cellular complexes that break down proteins. They are being studied in the treatment of cancer; and three are approved for use in treating multiple myeloma. (Chemistry) [100%] 2023-10-09 [Proteasome inhibitors]
3. Protease inhibitors: Protease inhibitors (PIs) are a class of medication used to treat or prevent infection by viruses, including HIV and Hepatitis C. PIs prevent viral replication by inhibiting the activity of HIV-1 protease, an enzyme used by the viruses to ... [91%] 2023-10-09 [Antivirals] [Antiretroviral drugs]...
4. Protease inhibitor: A protease inhibitor is a chemical compound that inhibits the functions of proteases to control viral infections, especially so for the treatment of HIV/AIDS and hepatitis C, but also for the treatment of other viruses, such as chicken pox ... [85%] 2022-03-06
5. Protease inhibitor (pharmacology): Protease inhibitors (PIs) are medications that act by interfering with enzymes that cleave proteins. Some of the most well known are antiviral drugs widely used to treat HIV/AIDS, hepatitis C and COVID-19. (Pharmacology) [85%] 2023-10-11 [Protease inhibitors]
6. Proteasome (prosome, macropain) subunit, alpha 1: Proteasome subunit alpha type-1 is a protein that in humans is encoded by the PSMA1 gene. This protein is one of the 17 essential subunits (alpha subunits 1-7, constitutive beta subunits 1-7, and inducible subunits including beta1i ... (Prosome, macropain) [80%] 2023-10-25
7. Proteasome: Proteasomes are protein complexes which degrade unneeded or damaged proteins by proteolysis, a chemical reaction that breaks peptide bonds. Enzymes that help such reactions are called proteases. (Protein complexes which degrade unnecessary or damaged proteins by proteolysis) [80%] 2024-03-03 [Proteins] [Protein complexes]...
8. Kunitz STI protease inhibitor: Kunitz soybean trypsin inhibitor is a type of protein contained in legume seeds which functions as a protease inhibitor. Kunitz-type Soybean Trypsin Inhibitors are usually specific for either trypsin or chymotrypsin. (Biology) [60%] 2023-10-12 [Protein domains]
9. Proteome: The proteome is the entire set of proteins that is, or can be, expressed by a genome, cell, tissue, or organism at a certain time. It is the set of expressed proteins in a given type of cell or organism ... (Biology) [60%] 2023-10-17 [Proteomics]
10. Protease: A protease (also called a peptidase, proteinase, or proteolytic enzyme) is an enzyme that catalyzes proteolysis, breaking down proteins into smaller polypeptides or single amino acids, and spurring the formation of new protein products. They do this by cleaving the ... (Biology) [60%] 2023-10-17 [EC 3.4]
11. Inheritors (play): Inheritors is a four-act play written by the American dramatist Susan Glaspell, first performed in 1921 (103 years ago) (1921). The play concerns the legacy of an idealistic farmer who wills his highly coveted midwest farmland to the establishment ... (Play) [54%] 2024-01-01 [1921 plays] [Plays by Susan Glaspell]...
12. Protein Z-related protease inhibitor: Protein Z-dependent protease inhibitor is a protein circulating in the blood which inhibits factors Xa and XIa of the coagulation cascade. It is a member of the class of the serine protease inhibitors (serpins). [54%] 2023-10-09 [Coagulation system] [Serine protease inhibitors]...
13. PCSK9 inhibitors: PCSK9 inhibitors are a class of medications used to treat hypercholesterolemia. In those on high doses of statins, they decrease risk of further problems by 1.5% over 2.5 years. [48%] 2024-01-01
14. PERK inhibitors: A PERK inhibitor is a small molecule compound that unlike any existing drug inhibits the expression of protein kinase RNA–like endoplasmic reticulum kinase. The (first such) inhibitor demonstrated the ability to halt brain cell death in mice with prion ... (Chemistry) [48%] 2023-12-17 [Protein kinase inhibitors]
15. PERK inhibitors: A PERK inhibitor is a small molecule compound that unlike any existing drug inhibits the expression of protein kinase RNA–like endoplasmic reticulum kinase. The (first such) inhibitor demonstrated the ability to halt brain cell death in mice with prion ... [48%] 2024-02-11 [Protein kinase inhibitors]
16. Lipase inhibitors: Lipase inhibitors are substances used to reduce the activity of lipases found in the intestine. Lipases are secreted by the pancreas when fat is present. [48%] 2023-12-19 [Lipase inhibitors] [Obesity]...
17. Phosphodiesterase inhibitors: Articles Most recent articles on Phosphodiesterase inhibitors Most cited articles on Phosphodiesterase inhibitors Review articles on Phosphodiesterase inhibitors Articles on Phosphodiesterase inhibitors in N Eng J Med, Lancet, BMJ Media Powerpoint slides on Phosphodiesterase inhibitors Images of Phosphodiesterase inhibitors Photos ... [48%] 2023-12-20 [Phosphodiesterase inhibitors] [Drugs]...
18. STAT inhibitors: STAT inhibitors are drugs which target signal transducer and activator of transcription (STAT) proteins, a family of cytoplasmic induction factors. Inhibitors of STAT proteins are being developed for use in cancer therapy. (Chemistry) [48%] 2023-12-15 [Enzyme inhibitors]
19. Angiokinase inhibitors: Angiokinase inhibitors are a new therapeutic target for the management of cancer. They inhibit tumour angiogenesis, one of the key processes leading to invasion and metastasis of solid tumours, by targeting receptor tyrosine kinases. (Chemistry) [48%] 2023-12-16 [Tyrosine kinase inhibitors]
20. Angiokinase inhibitors: Angiokinase inhibitors are a new therapeutic target for the management of cancer. They inhibit tumour angiogenesis, one of the key processes leading to invasion and metastasis of solid tumours, by targeting receptor tyrosine kinases. [48%] 2023-12-20 [Tyrosine kinase inhibitors]